Background. Cobalamin deficiency is responsible for hematological, neurological, neurocognitive, and neuropsychiatric impairments and is a risk factor for cardiovascular diseases, particularly in the elderly people.
C OBALAMIN (vitamin B12) deficiency, particularly in the elderly people, is not only a risk factor for heart disease and strokes but also neurological impairment, cognitive decline, and neuropsychiatric symptoms such as psychotic and mood symptoms (1) (2) (3) (4) . All these disorders are not only the most common signs of B12 deficiency but also are frequent without B12 deficiency in old patients.
B12 deficiency is mainly secondary to food-cobalamin malabsorption, pernicious anemia, and more rarely dietary deficiency but is easily treated thanks to the efficacy of oral or IM cobalamin treatments (5, 6) .
However, the biological characterization of B12 deficiency is not made easily. B12 serum concentration is never a good indicator of B12 cellular stock. Therefore, low level B12 serum concentration can be found in the absence of "true" deficiency. Homocystein (tHcy) or methylmalonic acid blood levels are more reliable indicators of intracellular vitamin B12 status and when these marker concentrations are increased they are highly sensitive indicators of "true" or functional B12 tissue deficiency (7) . However, tHcy level is also a marker for folate status or other disorders just like MTHFR mutations and renal dysfunction and is a major risk factor for cerebral, coronary, and peripheral vascular disease indicating that this biomarker cannot be considered per se as a marker of B12 tissue status (8) . Therefore, functional B12 deficiency is identified as a pathology with compound markers: low serum B12 concentration associated to high tHcy concentration. Thus, B12 deficiency has long been considered a rare pathology, but more recently, the recognition of subclinical cobalamin deficiency was demonstrated as a common finding, especially among the elderly people and points to a public health problem (9) . Identification of such deficiency in a very large cohort of hospitalized patients as well as correlations with other blood parameters just like hemoglobin level, mean cell volume (MCV), tHcy, or folate concentrations have not yet been reported.
The aim of this study were to screen a large cohort of inpatients for which B12 concentration measurements were performed in order to (i) analyze population distribution according to age and different biological values, (ii) evaluate potential correlation between all analyzed biological parameters, (iii) compare participants according to B12 and folate profiles, and (iv) compare biological values distributions and metabolic profiles according to age groups.
Methods

Study Population
The studied population included all consecutive patients admitted in the Henri Mondor (HM) University Hospital from January 1, 2011 to December 31, 2011 and who had serum B12 concentration measurements during this period. The HM University Hospital was composed of five structures in the Paris metropolitan area, France: HM hospital, Albert Chenevier Hospital, Emile Roux Hospital, JoffreDupuytren Hospital, and Georges Clemenceau Hospital. Among them, the last four are specialized in geriatric management, whereas HM is a general hospital. Duplicate or multiple blood measurements for a given patient were excluded. Only the first test performed during the study was selected for a given patient. Thus, the final analytic sample consisted of 14,904 measurements of different participants corresponding to 87.7% of all B12 analysis performed in the university hospital during the period. The study population was divided into three groups according to age: young people aged 16-30 years, adults aged 30-60 years, and elderly people aged >60 years. The elderly people were further divided into four subgroups by decade: 60-70 years, 70-80 years, 80-90 years, and >90 years. We excluded biological data on anyone younger than 16 years (n = 71) because these samples were not from inpatients of our institution. Data on supplementation with B12 or folate in patients were not available. The study complied with the Declaration of Helsinki and was approved by the Ile-deFrance Paris-IX ethics committee (Créteil, France).
Biological Parameters Studied
Blood measurements were centralized in one single laboratory of HM University Hospital. Each selected participant had a serum B12 concentration measurement. If serum B12 concentration was <350 ng/L, a tHcy measurement was performed in the same blood sample. We used serum vitamin B12 status based on the cutoffs proposed by Bailey and colleagues (10) in the 1999-2004 NHANES cohort of elderly individuals and reported as <200 ng/L (low), 200-350 ng/L (middle), and >350 ng/L (high).
We classified elevated tHcy as a concentration >17 µmol/L, based on local normal range. Among selected patients who had B12 test, we analyzed the following biochemical tests: folate serum concentration, hemoglobin concentration, and MCV if they were drawn. We considered low folate concentration when folate concentration was under 4 µg/L and high folate concentration when folate level was higher than 4 µg/L (11). Anemia was defined as hemoglobin concentrations <120 g/L in male and <110 g/L in female and severe anemia as hemoglobin concentration <100 g/L (12). Macrocytosis was defined as MCV >100 fl and microcytosis as MCV < 80 fl (13) .
Metabolic Profiles
We defined metabolic profiles according to B12 and folate concentrations. The B12 status was based on combinations of "normal" or "abnormal" vitamin B12 and tHcy serum concentrations, applying the most frequently used cutoffs for vitamin B12 < 350 ng/L and tHcy > 17 µmol/L. Profile 1 consisted of a serum vitamin B12 concentration < 350 ng/L associated with an elevated tHcy > 17 µmol/L. Participants with Profile 1 were classified as being functional B12 deficient. Profile 2 consisted of a serum vitamin B12 < 350 ng/L not associated with an elevated tHcy. Participants with Profile 2 were considered as false B12 deficient. Profile 3 included patients with a high serum vitamin B12 > 350 ng/L and were considered as non-B12 deficient. Individuals were classified as functional folate deficient if folate serum concentration was <4 µg/L accompanied by elevated tHcy concentration (>17 µmol/L) corresponding to Profile 4. Participants were false folate deficient if they had serum folate concentration <4 µg/L not associated with an elevated tHcy (Profile 5), and participants were nonfolate deficient if they had serum folate concentration >4 µg/L (Profile 6). Participants with Profile A classified as being functional B12 deficient only belonged to Profile 1 but not included in Profile 4 group. Participants with Profile B classified as being functional folates deficient only were individuals belonging to Profile 4 but not being included in Profile 1. Participants with Profile C classified as functional B12 and folates deficient belonged to both Profile 1 and Profile 4. Participants with Profile D were classified as being false B12 deficient only and corresponded to patients who belonged to both Profiles 2 and 6. Individuals classified as false folates deficient only corresponding to Profile E belonged to patients of both Profiles 5 and 3. Participants with Profile F were classified as false B12 and folates deficient and corresponded to patients of both Profiles 2 and 5. In addition, patients classified no B12/folates deficient (Profile G) belonged to both Profiles 3 and 6.
Laboratory Methods
B12, folates, and tHcy levels were measured on fresh or frozen stored samples according to an immuno-assay method (Advia Centaur, Siemens, France), hemoglobin and MCV were measured also on fresh samples with an automated Coulter-LH (Beckman Coulter, France) according to the manufacturer's instructions. The references to the total CV percentage for each test were: B12 from 3.8% to 10.4%, folate from 7.6% to 10%, and tHcy from 3.5 to 6.8% depending on metabolite concentration.
Statistical Methods
Descriptive results are presented as means (±SD) for continuous data and percentages for categorical data. Comparison analyses were first performed globally between the independent metabolic profiles as defined earlier and/ or increasing age categories, using the chi-square test for categorical variables, and the ANOVA or nonparametric Kruskal-Wallis test for continuous variables (detailed biological parameters) when non-normality was demonstrated by the use of the Shapiro-Wilk test for normality. In case of significance of the global tests, post-hoc pair wise comparisons between pre-specified groups or against the age of 30-60 years reference category were performed using unpaired t-test or nonparametric Mann-Whitney rank-sum tests, when appropriate, and correcting for multiple comparisons using the Bonferroni method. In addition, tests for trend were performed for the analysis of profiles and biological parameters as a function of increasing age categories, using chi-square (categorical data) or Jonckheere-Terpstra (continuous data) tests for trend. Finally, Spearman's rho correlation coefficients were computed to assess the relationships between biological parameters, using the Bonferroni method to correct p values for test multiplicity. A two-tailed p value of less than .05 was considered significant. Statistical analyses were performed using Stata software version 12.1 (StataCorp LP, College Station, TX).
Missing data were around 2% of all samples for folate measurement, 10% and 17% for Hemoglobin and MCV, and 47.5% for tHcy, this last parameter being only automatically realized if B12 or folates concentrations were low, respectively. B12 < 350 ng/L and folate <4 µg/L implies that practically all samples with low B12 level (<350 ng/L or low folate level [<4 µg/L] have tHcy measurement performed [93% and 78% for B12 and folates, respectively]).
Results
Cohort Distribution According to Age, B12, Folate, tHcy, Hemoglobin Concentrations, and MCV
From January 1, 2011 to December 31, 2011, B12 measurements were performed in 14,904 of 40,934 inpatients, corresponding to 36.4% of annual admissions in HM University Hospital. Firstly, we performed an analysis of the entire cohort according to age and to biological factors. Figure 1A reported study population distribution according to age. Mean age was 70.3 ± 19.5 years. The population distribution according to age was as follows: 16-30 years: 3.64%, 30-60 years: 24.99%, 60-70 years: 12.92%, 70-80 years: 17.45%, 80-90 years: 29.26%, and >90 years: 11.71%. Thus, the decade in which B12 measurement was at the highest percentage was with older participants (80-90 years). The median serum B12 concentration ( Figure 1B ) was 559 ± 352 ng/L.
The B12 concentration was low in 4.6%, average in 24.2%, and high in 71.2% of patients. The median serum folate concentration was 9.4 ± 6.8 µg/L and 20.4% of participants had low folate concentration ( Figure 1C) . Then, the median serum tHcy concentration was 19.6 ± 11.2 µmol/L. The tHcy level was normal in 42.9% of the cohort and elevated in 57.1% ( Figure 1D ). Hemoglobin concentration in this population was 117.9 ± 6.6 g/L with a flattened distribution curve from 110 to 135 g/L compatible with gender-differentiated hemoglobin concentrations ( Figure 1E ). Fifty-four percentage of the patients had hemoglobin level <120 g/L and 20% of the cohort presented severe anemia (<100 g/L). Finally, MCV measurements described a Gaussian curve ( Figure 1F ) with 9.3% of the participants presenting macrocytosis, 85.4% normal MCV, and 5.2% microcytosis. The median MCV was 91.9 ± 8 fl.
Correlation Between All Analyzed Biological Parameters
Correlations between B12, folates, tHcy concentrations, hemoglobin level, and MCV were analyzed (Table 1) . In brief, correlations existed between all these parameters, except not only for B12 or folate and MCV but also for tHcy and hemoglobin levels.
Comparison of Participants According to B12 and Folate Profiles
We analyzed data according to B12 and folate profiles ( Table 2) . Among the 14,904 patients, 1,704 (12.6%) were classified as functional B12 deficient (Profile 1), 1,205 (8.9%) false B12 deficient (Profile 2), and 10,562 (78.4%) as non-B12 deficient (Profile 3). Functional folate deficient patients were 1,452 (10.6%) (Profile 4), 743 (5.4%) were false folate deficient (Profile 5), and 11,551 (84%) were nonfolate deficient (Profile 6). Both functional B12 and folate deficient patients (Profile C) were 606 (4.7%). We observed 1,098 (8.5%) patients classified as functional B12 deficiency only (Profile A) and 846 (6.6%) as functional folate deficiency only (Profile B). Functional B12 deficient patients (Profile 1) had lower folate concentration and higher MCV but surprisingly had higher hemoglobin level than non-B12 deficient (Profile 3). Patients in Profile 1 had lower B12 and folate concentrations but higher hemoglobin level and MCV than patients in Profile 2. No statistical difference in B12, hemoglobin, and MCV were noticed between functional folate deficient patients (Profile 4) and false folate deficient patients (Profile 5). Patients in Profile 4 had higher MCV and lower B12 concentration than non-folate deficient patients (Profile 6). Participants with double functional deficiency (Profile C) had hemoglobin level and MCV not statistically different from that of all other patients. Participants in Profile C had higher B12 and tHcy concentrations but lower folate concentration than those with functional B12 deficiency only (Profile A). Patients in Profile C had also lower B12 but not folate concentrations than patients in Profile B and had also higher tHcy, hemoglobin level, and MCV than those in Profile B. Hemoglobin level was not different in patients in Profile C and in non-B-deficient patients (Profile G).
Biological Values Subgroups Distributions According to Age
The proportion of patients with low B12 concentration increased with age after 30 years (Figure 2A ). The proportion of patients with low folate concentration (<4 μg/L) increased with age only after 70 years, and in a parallel to the decrease of patients with very high folate concentration (>10 μg/L) ( Figure 2B ). For tHcy concentration, we also observed a decrease in the proportion of patients with low homocystein level (<17 μg/L) with age, except for the 70-80 years group ( Figure 2C) . The proportion of patients with hemoglobin >120 g/L decreased according to age >60 years but the proportion of patients with severe anemia (<100 g/L) did not increase with age, suggesting that the proportion of patients with hemoglobin level 100-120 g/L increased with age ( Figure 2D ). According to age, the proportion of microcytic patients decreased but the macrocytic patients were in the same order of magnitude after 60 years. In fact, the number of patients in the normocytic group increased with age ( Figure 2E ). The Gaussian curves confirmed this data ( Figure 2F ). In conclusion, the proportion of patients who had low B12 or folate concentrations and high tHcy concentration increased with age and the proportion of microcytic patients decreased with age.
Comparison of Biological Parameters According to Age Groups
We analyzed the different biological values according to the age groups defined earlier by using the adult group (30-60 years) as a reference group (Table 3A) . The B12 concentration was not different according to age decades, except for young people (16-30 years) with lower B12 concentration and for the decade 80-90 years with higher B12 concentration than the adult group. Folate concentration was similar in patients aged 16-80 years, except for older patients (>80 years) with a mean level in folate lower than adults, suggesting a direct age-related effect on folate status only in very old people. Similarly, hemoglobin concentration also demonstrated an age-related effect in the very old patients and in young people. Indeed, these two groups presented lower hemoglobin concentrations whereas no concentration difference was found in patients aged 30-70 years. The MCV appeared as a good marker directly correlated to age in this study. Despite a normocytic mean in all age groups, we found a regular significant increase in the mean MCV according to age from 87 fl (16-30 years) to 92.9 fl 565.82 ± 371.87
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Homocystein ( 92.63 ± 7.12 Participants aged 60-70 years had higher tHcy concentration and MCV than the reference group. Old patients with 70-80 years presented higher MCV and tHcy concentration and a lower hemoglobin level when compared with the reference group. Old patients with 80-90 years had lower folate and hemoglobin concentrations and had higher B12 and tHcy concentrations than the adult group. The old patients with >90 years had the same differences than the very old group with 80-90 years for B12 concentration which was not significantly different from the adult group.
Comparison of Metabolic Profiles According to Age Groups
Finally, we compared B deficient profiles according to age groups (Table 3B) . We observed that the number of patients classified as functional B12 deficient (Profile 1) but also those classified as functional folate deficient (Profile 4) and functional B12 deficiency only (Profile A) increased significantly and gradually with age, respectively, from 4.7% to 11.2%, from 5.7% to 12.1%, and from 4.7% to 11.2%. This increase with age was not reported in patients classified as double functional deficient (Profile C) and functional folate deficiency only (Profile B).
Discussion
This study reported one of the most extensive and unselected cohort of B12 measures performed in inpatients from one single European institution and consisted in more than 14,000 measures processed in one single laboratory corresponding to the largest study reported to our knowledge (10) . The aims of this study were to determine whether age had a clear impact on B12 and folate deficiencies as previously hypothesized but not demonstrated and also to evaluate correlations between B12 and different biological parameters as well as age.
In this cohort, serum B12 measurements, nearly systematically measured jointly with folate, were frequently performed in inpatients, particularly in the elderly people as recommended (1), whereas only 20% of these patients had hemoglobin concentration <100 g/L and only 9.3% of them were macrocytic. Low hemoglobin level and macrocytosis did not predict B12 deficiency as demonstrated before (14, 15) . The hematologic criteria did not seem to have motivated the practitioner to measure B12. The practitioner in the hospital probably required B12 measurements based on clinical and nonbiological criteria; he/she may also have required B12 measurements to evaluate risk factors for vascular disease or to investigate neurological, neurocognitive, and neuropsychiatric impairments, particularly in the elderly stage (≥80 years) that accounted for 40% of the measurements in this study.
Among the 14,904 inpatients in whom B12 measurements were performed, 4.6% had low B12 concentration (<200 ng/L), 24.2% had middle B12 concentration (200 to 350 ng/L) and 11.5% had functional B12 deficiency (B12 < 350 ng/L associated to tHcy > 17 μM/L). These results were close to those of previous studies: from 8 to 19% regarding functional B12 deficient (14, 16, 17) , from 4.9 to 7.2% regarding low B12 (14, (18) (19) (20) , and from 19 to 22% regarding middle B12 (10, 20) . By performing the dosage in 36.4% of total inpatients during 1 year, B12 deficiency was frequently sought in hospitals. However, deficiency was not observed more frequently in inpatients than in the studies performed on outpatients although we initially hypothesized that prevalence would be higher because patients were supposed to be sicker and frailer. Among these patients in whom B12 measurements were performed, 20.4% had low folate concentration (folate < 4 μg/L), 9.8% were functional folate deficient (folate < 4 μg/L associated to tHcy > 17 μM/L), which is in accordance with previous results (21, 22) .
Anemia was associated neither with B12 deficiency nor with folate deficiency. In fact, no correlation was found between hemoglobin level and other biological factors, suggesting that anemia was probably a consequence of multiple causes in these old inpatients (23) . Indeed, functional B12 or folate deficient patients were not more anemic than the other groups although the mean MCV was higher for these deficient patients, suggesting that probably the patients had not presented deep deficiencies for a very long time or that anemia did not occur frequently in these contexts. The increased MCV might also be present before anemia occurred.
There were a number of limitations to this analysis. Prevalence of vitamin B deficiency could be biased for different reasons. No data about vitamin supplementation in patients were reported. The prevalence of B deficiency could be under diagnosed. However, if duplicate or multiple measurements were performed, only the first one was kept on the database. Thus, we could expect that some patients with B supplementation were not included in the study. Then, elevated tHcy predictive of all-cause mortality, independent of frailty, is observed in case of dementia, renal impair function, cardiovascular event, whereas there is no B deficiency (24) (25) (26) . In reality, the prevalence of B deficient patients could be lower in this frail and aging population who probably had several comorbidities responsible for important tHcy elevation. Moreover, renal function influences tHcy levels but was not determined in the cohort, whereas renal function is often impaired in frail elderly.
We focused our study on age-related effects by analyzing age as a possible risk factor for vitamin B-deficiency and its association with the other studied biological parameters. In accordance with previous smaller scale studies, we observed a decrease in B12, folate (22, 27) , and hemoglobin concentrations (28, 29) and an increase in MCV and tHcy concentrations with age (30) (31) (32) (33) . The number of patients with low B12 concentration like those diagnosed as functional B12 deficient increased significantly with age demonstrating a direct age-related effect on B12 deficiency, especially for old patients. The age-related effects were also observed in patients with low folate concentration and in functional folate deficient patients. Our results in a large cohort study were in accordance with previous studies which demonstrated that the prevalence of B12 deficiency increased with age although different cut-offs made it difficult to compare results from different studies (34) (35) (36) (37) . Note that the results of the young people group (16-30 years) contrasted with those of other age groups because the young people in which B12 measurements were performed, were probably a specific population with co morbidities that were very different from those of other age groups and also because of the large number of thalassemic and sickle cell disease patients in our institution.
In conclusion, B deficiency was very frequently searched in inpatients although deficiency is not more common than in outpatients. This study demonstrated clearly an increased risk of functional B12 and folates deficiencies with age. We also demonstrated that B deficiency had to be suspected in inpatients whatever the hemoglobin level and MCV level are. Moreover, we confirmed that about half of the low B12 concentrations measured in routine practice in hospital were not "true"/functional B12 deficient patients because tHcy was not elevated. These false B12 deficient patients probably corresponded to transcobalamin I deficients (B12 < 200 ng/L associated with normal tHcy level (38) ). This sub-group of probable transcobalamin I deficiency patients seemed to be frequent and was stable whatever the age. These findings illustrated that in the context of low B12 measurement, tHcy measurement in clinical practice was indicated to confirm vitamin deficiency and eliminated transcobalamin I deficiency that did not need to be treated with B12 supplementation.
